Related references
Note: Only part of the references are listed.First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes
Min Feng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma
Kristin Hinton et al.
BIOMOLECULES (2023)
Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways
Jiaojiao Yu et al.
BIOCHEMICAL PHARMACOLOGY (2022)
PDGFRI3 modulates aerobic glycolysis in osteosarcoma HOS cells via the PI3K/AKT/mTOR/c-Myc pathway
Hu-ying Tang et al.
BIOCHEMISTRY AND CELL BIOLOGY (2022)
Ligand-activated PPAR delta expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
Wei Han et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway
Jianping Zheng et al.
MOLECULAR MEDICINE REPORTS (2022)
Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt/β-catenin and PI3K/Akt signaling pathways
Yuping Wang et al.
ONCOLOGY REPORTS (2022)
MicroRNA-886 suppresses osteosarcoma cell proliferation and its maturation is suppressed by long non-coding RNA OXCT1-AS1
Wen Dai et al.
BIOENGINEERED (2022)
miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway
Chao Yang et al.
JOURNAL OF ONCOLOGY (2022)
MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway
L. F. Gao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
miR-29a-3p mitigates the development of osteosarcoma through modulating IGF1 mediated PI3k/Akt/FOXO3 pathway by activating autophagy
Song Qi et al.
CELL CYCLE (2022)
VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
Zhangya Pu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis
Mengjun Zhang et al.
MOLECULAR MEDICINE (2022)
MicroRNA-181a-5p Promotes Osteosarcoma Progression via PTEN/AKT Pathway
Chen Sun et al.
ANALYTICAL CELLULAR PATHOLOGY (2022)
TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway
Dongsheng Zhu et al.
ONCOLOGY LETTERS (2022)
Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis
Wei Wu et al.
BIOENGINEERED (2022)
MiR-451a promotes cell growth, migration and EMT in osteosarcoma by regulating YTHDC1-mediated m6A methylation to activate the AKT/mTOR signaling pathway
Dong Cao et al.
JOURNAL OF BONE ONCOLOGY (2022)
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways
He Pang et al.
JOURNAL OF BONE ONCOLOGY (2022)
MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
Negin Soghli et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p
Yongheng Liu et al.
CANCER CELL INTERNATIONAL (2022)
Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer
Lin Shi et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathway
Rui Zhang et al.
DISCOVER ONCOLOGY (2022)
ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
Yong Cui et al.
Aging-US (2022)
STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2
Dong Zhang et al.
CANCER BIOLOGY & THERAPY (2022)
Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silviu Stanciu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers
Yang Shen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3
Dan Zu et al.
JOURNAL OF ONCOLOGY (2022)
Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
Zhixing Chen et al.
JOURNAL OF ONCOLOGY (2022)
Circular RNA ROCK1, a novel circRNA, suppresses osteosarcoma proliferation and migration via altering the miR-532-5p/PTEN axis
Yize Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
HTR1D functions as a key target of HOXA10-AS/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway
Wu Wu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Non-coding RNAs: the new central dogma of cancer biology
Phei Er Saw et al.
SCIENCE CHINA-LIFE SCIENCES (2021)
CHRDL2 promotes osteosarcoma cell proliferation and metastasis through the BMP-9/PI3K/AKT pathway
Houping Chen et al.
CELL BIOLOGY INTERNATIONAL (2021)
Phosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition
Ruth Nussinov et al.
MOLECULAR CANCER RESEARCH (2021)
CCL4 Stimulates Cell Migration in Human Osteosarcoma via the mir-3927-3p/Integrin αvβ3 Axis
Hsiao-Chi Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling
Binbin Deng et al.
CANCER MANAGEMENT AND RESEARCH (2021)
ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway
Hongyu Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Down-regulation of circular RNA hsa_circ_0007534 suppresses cell growth by regulating miR-219a-5p/SOX5 axis in osteosarcoma
Peng Zhang et al.
JOURNAL OF BONE ONCOLOGY (2021)
The role of microRNAs in bone development
Austin P. Hensley et al.
BONE (2021)
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
Sepideh Mirzaei et al.
LIFE SCIENCES (2021)
CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway
Lei Wang et al.
MOLECULAR CANCER (2021)
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Low-dose mono(2-ethylhexyl) phthalate promotes ovarian cancer development through PPARα-dependent PI3K/Akt/NF-κB pathway
Jing Leng et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2021)
KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway
Songjia Ni et al.
FRONTIERS IN ONCOLOGY (2021)
HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway
Kun Ma et al.
Journal of Cancer (2021)
MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway
Liang Fan et al.
BIOENGINEERED (2021)
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway
Wacili Da et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
Yue-chu Dai et al.
FRONTIERS IN ONCOLOGY (2021)
CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis
Zuowei Shi et al.
FRONTIERS IN ONCOLOGY (2021)
Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis
Liang Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
Suresh Mickymaray et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
Osteosarcoma Cell-Derived Small Extracellular Vesicles Enhance Osteoclastogenesis and Bone Resorption Through Transferring MicroRNA-19a-3p
Tingting Luo et al.
FRONTIERS IN ONCOLOGY (2021)
Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma
Kexiang Zhang et al.
Aging-US (2021)
Long noncoding RNA GAS8-AS1: A novel biomarker in human diseases
Ganglei Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Apatinib inhibits cell proliferation and migration of osteosarcoma via activating LINC00261/miR-620/PTEN axis
Gang Han et al.
CELL CYCLE (2021)
CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K-Akt-mTOR pathway inhibition
Yu-Xin Liao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
Zhen Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis
Bingsheng Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway
Ming-Yang Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-kappa B signaling pathway
Jiayao Qu et al.
CELL AND BIOSCIENCE (2021)
Dieckol exerts anticancer activity in human osteosarcoma (MG-63) cells through the inhibition of PI3K/AKT/mTOR signaling pathway
Shouqiang Zhang et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
Lauren K. Jillson et al.
CANCERS (2021)
BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer
Xiong Shu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway
Xin Zhao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
MicroRNA-9 and breast cancer
Xiaoman Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway
Qing Liu et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2020)
MicroRNA-22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway
Chen-Yang Meng et al.
ONCOLOGY REPORTS (2020)
miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma
Chuan He et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
The Effects of Interleukin-33 (IL-33) on Osteosarcoma Cell Viability, Apoptosis, and Epithelial-Mesenchymal Transition are Mediated Through the PI3K/AKT Pathway
Shenyu Wang et al.
MEDICAL SCIENCE MONITOR (2020)
Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142
Longqiang Zhang et al.
MEDICAL SCIENCE MONITOR (2020)
Long Non-Coding RNA 691 Regulated PTEN/PI3K/AKT Signaling Pathway in Osteosarcoma Through miRNA-9-5p
Pengju Yao et al.
ONCOTARGETS AND THERAPY (2020)
MicroRNA-744 promotes proliferation of osteosarcoma cells by targeting PTEN
Wei Yu et al.
MOLECULAR MEDICINE REPORTS (2020)
Alternative splicing of leptin receptor overlapping transcript in osteosarcoma
Emel Rothzerg et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2020)
被撤回的出版物: Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN (Retracted article. See vol. 18, pg. 3283, 2023)
Lingling Ou et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
miRNA-216 knockdown has effects to suppress osteosarcoma via stimulating PTEN
Ping Jiang et al.
FOOD SCIENCE & NUTRITION (2020)
TBRG4 Knockdown Suppresses Proliferation and Growth of Human Osteosarcoma Cell Lines MG63 Through PI3K/Akt Pathway
Fei Huang et al.
ONCOTARGETS AND THERAPY (2020)
Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway
Xinbo Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Piceatannol suppresses proliferation and induces apoptosis by regulation of the microRNA-21/phosphatase and tensin homolog/protein kinase B signaling pathway in osteosarcoma cells
Mingyue Zheng et al.
MOLECULAR MEDICINE REPORTS (2020)
MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN
Yutuo Fu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2
Limin Sun et al.
ONCOLOGY LETTERS (2020)
Soft Substrate Promotes Osteosarcoma Cell Self-Renewal, Differentiation, and Drug Resistance Through miR-29b and Its Target Protein Spin 1
Shun Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Formononetin inhibits osteosarcoma cell proliferation and promotes apoptosis by regulating the miR-214-3p/phosphatase and tensin homolog pathway
Kang Li et al.
TRANSLATIONAL CANCER RESEARCH (2020)
MNAT1 promotes proliferation and the chemo-resistance of osteosarcoma cell to cisplatin through regulating PI3K/Akt/mTOR pathway
Chensheng Qiu et al.
BMC CANCER (2020)
MiR-1224-5p Activates Autophagy, Cell Invasion and Inhibits Epithelial-to-Mesenchymal Transition in Osteosarcoma Cells by Directly Targeting PLK1 Through PI3K/AKT/mTOR Signaling Pathway
Bicheng Jin et al.
ONCOTARGETS AND THERAPY (2020)
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways
Yanran Huang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
Interleukin-1/nuclear factor-B signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis
Weiguo Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
Hsien Liu et al.
BMC CANCER (2019)
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
Li Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting PI3K signaling in cancer: Challenges and advances
Maria Chiara De Santis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells
Lifeng Ma et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP
Yang Wang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Upregulation of miR-214 Induced Radioresistance of Osteosarcoma by Targeting PHLDA2 via PI3K/Akt Signaling
Yi Li et al.
FRONTIERS IN ONCOLOGY (2019)
Diallyl Disulfide Induces Apoptosis and Autophagy in Human Osteosarcoma MG-63 Cells through the PI3K/Akt/mTOR Pathway
Ziqi Yue et al.
MOLECULES (2019)
A hidden human proteome encoded by 'non-coding' genes
Shaohua Lu et al.
NUCLEIC ACIDS RESEARCH (2019)
Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway
Hongzhi Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway
Leichao Liu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
COX-2 promotes epithelial-mesenchymal transition and migration in osteosarcoma MG-63 cells via PI3K/AKT/NF-κB signaling
Xueliang Zhang et al.
MOLECULAR MEDICINE REPORTS (2019)
Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication
Jianfang Niu et al.
FRONTIERS IN ONCOLOGY (2019)
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAAT/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p
Lei Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5
Fei Ye et al.
GENE (2019)
Deciphering miRNAs' Action through miRNA Editing
Marta Correia de Sousa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance
Kun-Peng Zhu et al.
MOLECULAR THERAPY (2019)
Sodium cantharidinate suppresses human osteosarcoma MG-63 cell proliferation and induces cell cycle arrest by inhibition of PI3K/AKT activation
Da-Liang Kong et al.
ONCOLOGY REPORTS (2019)
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway
Ze-Yu Sun et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
MicroRNA-17 promotes osteosarcoma cells proliferation and migration and inhibits apoptosis by regulating SASH1 expression
Dajiang Wu et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1
Gentao Fan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2019)
MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis
Fang-Biao Zhan et al.
YONSEI MEDICAL JOURNAL (2019)
Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression
Xin Zhao et al.
ONCOLOGY REPORTS (2018)
Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN
Chen Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
miR-144 suppresses proliferation and induces apoptosis of osteosarcoma cells via direct regulation of mTOR expression
Yuan-Fei Ren et al.
ONCOLOGY LETTERS (2018)
MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression
Wang Jiashi et al.
AGING-US (2018)
SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma
Chao Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway
Jing Chen et al.
CHEMOTHERAPY (2018)
MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway
Long Zhang et al.
FEBS JOURNAL (2018)
The role of mTOR-mediated signaling in the regulation of cellular migration
Ailsa K. Holroyd et al.
IMMUNOLOGY LETTERS (2018)
Honokiol suppresses proliferation and induces apoptosis via regulation of the miR-21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells
Jiexiang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Noncoding RNA:RNA Regulatory Networks in Cancer
Jia Jia Chan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27
Jing Ding et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-kappa B-miR-21 pathways
Su-Jie Ni et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
MicroRNA-124 suppresses growth and aggressiveness of osteosarcoma and inhibits TGF-β-mediated AKT/GSK-3β/SNAIL-1 signaling
Bo Yu et al.
MOLECULAR MEDICINE REPORTS (2018)
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Yu-Ru Lee et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway
Rui Jin et al.
ONCOLOGY REPORTS (2018)
Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway
Jianwei Zhu et al.
CELL DEATH & DISEASE (2018)
MicroRNA-499a-5p inhibits osteosarcoma cell proliferation and differentiation by targeting protein phosphatase 1D through protein kinase B/glycogen synthase kinase 3β signaling
Jun Liu et al.
ONCOLOGY LETTERS (2018)
miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-1 signaling pathway
Xiaoming Hu et al.
ONCOLOGY LETTERS (2018)
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
Gillian L. Dornan et al.
FRONTIERS IN IMMUNOLOGY (2018)
MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma
Ming Zhuang et al.
CANCER CELL INTERNATIONAL (2018)
LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma
Ruida Xu et al.
CELL PROLIFERATION (2018)
TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis
Guo-sheng Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
PI 3-Kinase Signaling: AKTing up inside the Cell
Alex Toker et al.
MOLECULAR CELL (2018)
被撤回的出版物: miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma (Retracted article. See vol. 16, pg. 497, 2023)
Jiashi Wang et al.
ONCOTARGETS AND THERAPY (2018)
Intracytoplasmic Re-localization of miRISC Complexes
Bunyamin Akgul et al.
FRONTIERS IN GENETICS (2018)
miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma
Gan Gao et al.
CANCER CELL INTERNATIONAL (2018)
miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma
Rui-Da Xu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2018)
Non-coding RNAs as drug targets
Masayuki Matsui et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Novel insights and therapeutic interventions for pediatric osteosarcoma
Leo Kager et al.
FUTURE ONCOLOGY (2017)
PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway
Dong Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway
Bin Zhu et al.
ONCOLOGY REPORTS (2017)
miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway
Jie Xiao et al.
ONCOLOGY REPORTS (2017)
MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma
Yufeng Liu et al.
ONCOLOGY RESEARCH (2017)
Procaine Inhibits Proliferation and Migration and Promotes Cell Apoptosis in Osteosarcoma Cells by Upregulation of MicroRNA-133b
Boda Ying et al.
ONCOLOGY RESEARCH (2017)
Triptolide inhibits the growth of osteosarcoma by regulating microRNA-181a via targeting PTEN gene in vivo and vitro
Chunming Jiang et al.
TUMOR BIOLOGY (2017)
Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
Binwu Hu et al.
ONCOTARGETS AND THERAPY (2017)
MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma
Chen Wang et al.
SCIENTIFIC REPORTS (2017)
BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway
Shuming Gao et al.
DNA AND CELL BIOLOGY (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling
Lingqiang Chen et al.
ANNALS OF HEMATOLOGY (2016)
MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion via Targeting IGF-1R
Guangnan Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
Pablo Berlanga et al.
MOLECULAR ONCOLOGY (2016)
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Jesse M. Engreitz et al.
NATURE (2016)
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN
Jiansong Chen et al.
ONCOLOGY REPORTS (2016)
NON-CODING RNAs IN DEVELOPMENT AND DISEASE: BACKGROUND, MECHANISMS, AND THERAPEUTIC APPROACHES
Julia Beermann et al.
PHYSIOLOGICAL REVIEWS (2016)
MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR
Yang Liu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway
Chen Lv et al.
TUMOR BIOLOGY (2016)
Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN
Hao Zhang et al.
ONCOLOGY LETTERS (2016)
Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
Tomohiro Fujiwara et al.
STEM CELLS INTERNATIONAL (2016)
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism
Jianrong Lu et al.
CANCER LETTERS (2015)
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
Xue-jun Shao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
Seiji Mabuchi et al.
GYNECOLOGIC ONCOLOGY (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells
Masanori Kawano et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
miR-214 promotes osteosarcoma tumor growth and metastasis by decreasing the expression of PTEN
Chun-Jie Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis
G. Maric et al.
ONCOGENE (2015)
MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression
Hongmou Yuan et al.
ONCOLOGY REPORTS (2015)
MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA
Zhi-cai Shi et al.
TUMOR BIOLOGY (2015)
VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma
Dong Zhao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Less understood issues: p21Cip1 in mitosis and its therapeutic potential
N-N Kreis et al.
ONCOGENE (2015)
MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1
Xinyu Tan et al.
BONE RESEARCH (2015)
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
Merritt P. Edlind et al.
ASIAN JOURNAL OF ANDROLOGY (2014)
miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression
Yong Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
Marieke L. Kuijjer et al.
BMC MEDICAL GENOMICS (2014)
Osteosarcoma treatment - Where do we stand? A state of the art review
Anja Luetke et al.
CANCER TREATMENT REVIEWS (2014)
MicroRNA-141 and MicroRNA-146b-5p Inhibit the Prometastatic Mesenchymal Characteristics through the RNA-binding Protein AUF1 Targeting the Transcription Factor ZEB1 and the Protein Kinase AKT
Huda H. Al-Khalaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway
Kyu-Shik Lee et al.
MOLECULAR MEDICINE REPORTS (2014)
MicroRNA-214 regulates osteosarcoma survival and growth by directly targeting phosphatase and tensin homolog
Xuming Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
microRNA-25 promotes osteosarcoma cell proliferation by targeting the cell-cycle inhibitor p27
Xiu-Hui Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
Inhibition of the PI3K/Akt/mTOR Signaling Pathway in Diffuse Large B-Cell Lymphoma: Current Knowledge and Clinical Significance
Agata Majchrzak et al.
MOLECULES (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
MicroRNA-1 functions as a potential tumor suppressor in osteosarcoma by targeting Med1 and Med31
Chaoyin Jiang et al.
ONCOLOGY REPORTS (2014)
miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
Fei Guo et al.
ONCOLOGY REPORTS (2014)
The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase
Shunsuke Mori et al.
PLOS ONE (2014)
Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma
Zheng Tian et al.
ONCOTARGETS AND THERAPY (2014)
Molecular mechanisms of chemoresistance in osteosarcoma
Hongtao He et al.
ONCOLOGY LETTERS (2014)
Glaucocalyxin A, a negative Akt regulator, specifically induces apoptosis in human brain glioblastoma U87MG cells
Xian Xiao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy
Aamir Ahmad et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro
Tao Fang Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation
Jianli Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Insulin resistance and cancer: the role of insulin and IGFs
Sefirin Djiogue et al.
ENDOCRINE-RELATED CANCER (2013)
Core promoter analysis of porcine Six1 gene and its regulation of the promoter activity by CpG methylation
Wangjun Wu et al.
GENE (2013)
PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α
Anne Klotzsche-von Ameln et al.
MOLECULAR CANCER RESEARCH (2013)
Nutrient regulation of the mTOR Complex 1 signaling pathway
Sang Gyun Kim et al.
MOLECULES AND CELLS (2013)
MicroRNA-221 Induces Cell Survival and Cisplatin Resistance through PI3K/Akt Pathway in Human Osteosarcoma
Guangyi Zhao et al.
PLOS ONE (2013)
MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis
Huafu Zhao et al.
PLOS ONE (2013)
Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer
Zhen-Jun Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Heat Shock Protein 90B1 Plays an Oncogenic Role and is a Target of microRNA-223 in Human Osteosarcoma
Guodong Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-C
Aleksandar Kuzmanov et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts
Riccardo Di Fiore et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
PI3K-independent AKT activation in cancers: A treasure trove for novel therapeutics
Kiran Mahajan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou
JOURNAL OF THORACIC ONCOLOGY (2012)
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
Sophia Y. Lunt et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Twenty Years of Follow-Up of Survivors of Childhood Osteosarcoma
Rajaram Nagarajan et al.
CANCER (2011)
Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway
Lijun He et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Appraising the Current Role of Chemotherapy for the Treatment of Sarcoma
David R. D'Adamo
SEMINARS IN ONCOLOGY (2011)
Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway
Li Wen Gao et al.
TOXICOLOGY IN VITRO (2011)
Homeoprotein Six1 Increases TGF-β Type I Receptor and Converts TGF-β Signaling from Suppressive to Supportive for Tumor Growth
Douglas S. Micalizzi et al.
CANCER RESEARCH (2010)
Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
Beate M. Lichtenberger et al.
CELL (2010)
Eaten alive: a history of macroautophagy
Zhifen Yang et al.
NATURE CELL BIOLOGY (2010)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
MicroRNAs in Cancer
Yong Sun Lee et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
The binding of von Willebrand factor type C domains of Chordin family proteins to BMP-2 and Tsg is mediated by their SD1 subdomain
Takuo Fujisawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
Stefano Ferrari et al.
CURRENT OPINION IN ONCOLOGY (2007)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Processing of primary microRNAs by the Microprocessor complex
AM Denli et al.
NATURE (2004)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane
SM Maira et al.
SCIENCE (2001)
PKB/AKT: Functional insights from genetic models
MP Scheid et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
